Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tvardi Therapeutics ( (TVRD) ) has issued an update.
Tvardi Therapeutics has scheduled its 2026 Annual Meeting of Stockholders for June 9, 2026, and set March 16, 2026 as the deadline for shareholder proposals to be considered for inclusion in its proxy materials under SEC Rule 14a-8. Under the company’s bylaws, March 16, 2026 is also the cutoff for advance notice of director nominations and other business, while shareholders intending to solicit proxies for alternative director nominees under the SEC’s universal proxy rule must provide the required Rule 14a-19 notice by April 10, 2026, or risk losing the ability to have their proposals fully considered, thereby reinforcing clear governance and procedural timelines for investors ahead of the meeting.
The most recent analyst rating on (TVRD) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Tvardi Therapeutics stock, see the TVRD Stock Forecast page.
Spark’s Take on TVRD Stock
According to Spark, TipRanks’ AI Analyst, TVRD is a Neutral.
The score is primarily constrained by weak financial performance (sharp revenue decline, ongoing losses, negative operating cash flow, and negative equity). Technicals are mixed with only modest near-term support but a weak longer-term trend. Corporate events are a moderate offset due to upcoming catalysts, but recent mixed clinical readouts keep risk elevated, and valuation is not supportive given loss-making status.
To see Spark’s full report on TVRD stock, click here.
More about Tvardi Therapeutics
Tvardi Therapeutics, Inc. is a biopharmaceutical company focused on developing targeted therapies, operating as a publicly held corporation with stockholders who participate in corporate governance through annual meetings and proxy voting under U.S. securities regulations.
Average Trading Volume: 90,224
Technical Sentiment Signal: Sell
Current Market Cap: $37.71M
Find detailed analytics on TVRD stock on TipRanks’ Stock Analysis page.